PharmaEngine, Inc.

TPEX:4162 Stock Report

Market Cap: NT$14.9b

PharmaEngine Future Growth

Future criteria checks 1/6

PharmaEngine is forecast to grow earnings and revenue by 8.6% and 5% per annum respectively while EPS is expected to grow by 7.9% per annum.

Key information

8.6%

Earnings growth rate

7.9%

EPS growth rate

Biotechs earnings growth48.2%
Revenue growth rate5.0%
Future return on equityn/a
Analyst coverage

Low

Last updated06 Nov 2024

Recent future growth updates

Recent updates

Would PharmaEngine, Inc. (GTSM:4162) Be Valuable To Income Investors?

Mar 30
Would PharmaEngine, Inc. (GTSM:4162) Be Valuable To Income Investors?

How Much Did PharmaEngine's(GTSM:4162) Shareholders Earn From Share Price Movements Over The Last Five Years?

Feb 18
How Much Did PharmaEngine's(GTSM:4162) Shareholders Earn From Share Price Movements Over The Last Five Years?

Is PharmaEngine, Inc.'s (GTSM:4162) Stock On A Downtrend As A Result Of Its Poor Financials?

Jan 14
Is PharmaEngine, Inc.'s (GTSM:4162) Stock On A Downtrend As A Result Of Its Poor Financials?

We're Not Counting On PharmaEngine (GTSM:4162) To Sustain Its Statutory Profitability

Dec 10
We're Not Counting On PharmaEngine (GTSM:4162) To Sustain Its Statutory Profitability

Earnings and Revenue Growth Forecasts

TPEX:4162 - Analysts future estimates and past financials data (TWD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025932419N/A1,7782
12/31/2024912435N/A2381
6/30/2024860359326328N/A
3/31/2024764275250251N/A
12/31/2023768275257257N/A
9/30/2023739291217218N/A
6/30/2023648298283286N/A
3/31/2023649303225229N/A
12/31/2022654319198202N/A
9/30/2022700377260264N/A
6/30/2022722362216217N/A
3/31/2022713447301301N/A
12/31/2021655426929930N/A
9/30/20211,237837829829N/A
6/30/20211,156782831832N/A
3/31/20211,088631713713N/A
12/31/20201,0566046465N/A
9/30/20203444578N/A
6/30/2020330502323N/A
3/31/2020320643838N/A
12/31/2019314431616N/A
9/30/2019317114121121N/A
6/30/2019375164153153N/A
3/31/20193382069595N/A
12/31/2018293129745745N/A
9/30/20181,000647674675N/A
6/30/2018890569568569N/A
3/31/2018877463N/A496N/A
12/31/2017854387N/A-339N/A
9/30/2017875452N/A465N/A
6/30/2017849364N/A406N/A
3/31/20171,144607N/A763N/A
12/31/20161,135690N/A870N/A
9/30/201633042N/A63N/A
6/30/2016330168N/A530N/A
3/31/2016502383N/A426N/A
12/31/2015507394N/A448N/A
9/30/2015511393N/A654N/A
6/30/2015724552N/A272N/A
3/31/2015231100N/A111N/A
12/31/2014229124N/A131N/A
9/30/2014234135N/A-59N/A
6/30/201428-128N/A-60N/A
3/31/201434-116N/A-53N/A
12/31/201337-118N/A-47N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4162's forecast earnings growth (8.6% per year) is above the savings rate (1.1%).

Earnings vs Market: 4162's earnings (8.6% per year) are forecast to grow slower than the TW market (19% per year).

High Growth Earnings: 4162's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4162's revenue (5% per year) is forecast to grow slower than the TW market (12.3% per year).

High Growth Revenue: 4162's revenue (5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 4162's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y